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Abstract
Background: Asymptomatic bacteriuria (ABU) is common and often leads to unnecessary antimicrobial use.
Reducing antibiotic overuse for ABU is therefore an important issue for antimicrobial stewardship. We performed
this study to investigate the appropriateness of ABU management and to evaluate physicians’ knowledge and
practice regarding ABU.
Methods: We reviewed all urine cultures of ≥105 cfu/mL of bacteria among inpatients in a 900-bed hospital in
2011. Each episode of bacteriuria was classified into ABU or urinary tract infection (UTI). ABU was defined as a
positive urine culture (≥105 cfu/mL) without symptoms or signs suggesting UTI. In October 2012 a cross-sectional
survey of resident physicians was undertaken using an anonymous, self-administered questionnaire.
Results: We identified 219 ABU cases among 1167 positive urine cultures, of which 70 (32.0 %) were
inappropriately treated. Female gender, old age, pyuria, hematuria, and positive nitrite on urinalysis were associated
with inappropriate ABU treatment in a multivariate analysis (P < 0.05).
The response rate to the survey was 74.2 % (95/128). The mean knowledge score was 37.3 %, and 33.7 % of
respondents were able to distinguish ABU from UTI, but less than half knew the indications for treating ABU. Even
after ABU was correctly diagnosed, concerns about postoperative infections (38.6 %), UTI (9.1 %), and abnormal
urinalysis (29.5 %) prevented proper management. About half of the respondents reported to prescribing antibiotics
for ABU despite knowing they were not indicated.
Conclusions: About one third of ABUs were inappropriately managed. Lack of knowledge and discrepancies
between knowledge and practice, contributed to antimicrobial overuse for ABU. Our findings highlight the
importance of developing interventions, including education, audit and feedback, to tackle the problem of
inappropriate treatment of ABU.
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Background
Urinary tract infection (UTI) is the most common
nosocomial infection, accounting for about 40 % of
healthcare-associated infections [1]. However, asymp-
tomatic bacteriuria (ABU) is also prevalent, and often
misdiagnosed as UTI leading to inappropriate anti-
microbial use [2–6]. Antibiotic overuse has several
adverse effects, including the emergence of multidrug
resistant organisms, adverse drug reactions, Clostrid-
ium difficile infection, and increased costs of health
care [7–9].
Although current guidelines suggest screening for
ABU and treating it in specific circumstances such as
during pregnancy or before invasive urologic procedures,
antibiotic overuse for ABU seems to be overwhelming in
clinical practice, as supported by several studies report-
ing that 20–80 % of cases of ABU are inappropriately
treated [4–6, 10, 11]. Studies have shown that patients’
advanced age, the causative organism, and pyuria are fac-
tors associated with unnecessary ABU treatment [4, 5].
Physicians’ lack of knowledge and misperceptions also
contribute to the misuse of antibiotics [12, 13].
Reducing unnecessary antibiotic use for ABU is a
high-yield area in the antibiotic stewardship program,
considering the large amounts of antibiotics used for
UTI in hospitalized patients and the frequent misdiagnosis
of ABU as UTI [14]. It is also an important component
of performance measures and quality improvement in
patient care [15, 16].
In order to optimize antibiotic use and improve
guideline-compliant practices, it is crucial to assess pre-
vailing practice and identify realistic targets. However,
the issues of bacteriuria management and its associated
factors in Korea have not been investigated. Therefore,
we performed this study to assess the appropriateness
of ABU management and to evaluate clinical and
physician-related factors including knowledge, percep-
tion, and practice regarding ABU. This information
should be valuable for designing further interventions
to enhance the proper management of bacteriuria.
Methods
Case selection and data collection
We retrospectively reviewed all the positive urine cul-
tures obtained from the adult inpatients, from January
to December in 2011, in a 900-bed university-affiliated
tertiary care hospital in Korea. Positive urine cultures
were defined as the presence of bacteria or yeast ≥105 cfu/
mL, because only cultures yielding ≥105 cfu/mL of micro-
organisms are routinely reported in the hospital unless
there is a request for reporting low-count bacteriuria.
Since the unit of analysis in our study was a single episode
of bacteriuria, repeated bacteriuria examinations of a
single patient were counted as separate events. Urine
cultures made among patients in the emergency room or
outpatient departments were not reviewed. Similarly ex-
cluded were urine cultures from 1) pregnant women, 2)
patients undergoing invasive urologic procedures, and 3)
patients with concomitant infections receiving antibiotics
for infections other than UTI at the time of urine collec-
tion. Urine cultures made within seven days of a previous
bacteriuric event were excluded as these were likely to in-
volve the same episode of bacteriuria. Urine cultures per-
formed within 48 h of admission were also excluded as
these would represent episodes of bacteriuria with onset
before admission and therefore hard to assess. However,
since we did not try to distinguish between catheter-
associated bacteriuria and non-catheter- associated, pa-
tients with urine catheters were included.
We applied standardized criteria for diagnosing ABU
and UTI, modified from the Centers for Disease Control
and Prevention surveillance criteria as well as the 2005
Infectious Disease Society of America (IDSA) guidelines
[10, 17]. UTI was defined as the presence of bacteriuria or
funguria ≥105 cfu/mL along with at least one of the fol-
lowing symptoms and signs with no other recognized
cause: fever (temperature ≥37.8 °C), dysuria, urgency, fre-
quency, suprapubic tenderness, and costovertebral angle
pain or tenderness. ABU was defined as bacteriuria or fun-
guria ≥105 cfu/mL, without any symptoms or signs sug-
gesting UTI. We did not confine ABU or UTI to
bacteriuria involving no more than 2 species of microor-
ganisms, as we were not concerned to distinguish between
true bacteriuria and contamination. Antibiotic use for
ABU, except for pregnant patients and those undergoing
traumatic urologic procedures in which mucosal bleeding
is anticipated, is regarded as inappropriate, according to
the IDSA guidelines [10]. Two infectious diseases (ID)
specialists independently reviewed the medical records of
patients with positive urine cultures and classified each
bacteriuric episode as ABU or UTI and assessed the ap-
propriateness of management. If the two opinions differed,
another ID specialist was consulted and the final decision
was made by majority.
In order to identify clinical factors associated with anti-
biotic use for ABU, we collected data on patient demo-
graphics, the admitting department, underlying disease
including diabetes mellitus, chronic kidney disease, spinal
cord injury and solid tumor, as well as indwelling urinary
catheter, organisms found in urine culture, urinalysis and
other laboratory findings, body temperature and antibiotic
use.
Our study was approved by the institutional review
board of Seoul National University Bundang Hospital.
Survey of physicians regarding ABU
We conducted a cross-sectional survey over two weeks in
October 2012, using an anonymous, self-administered,
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paper-based questionnaire to evaluate physician-related
factors affecting ABU management. All resident physi-
cians were eligible for the survey, except pediatricians and
those affiliated with departments without hospitalized
patients, namely radiology, pathology, anesthesiology, nu-
clear medicine, laboratory medicine, and radiation oncol-
ogy. Resident physician was defined as a person enrolled
in the official 4-year-long resident training program after
finishing 1 year of internship. Although senior doctors
often influence junior doctors when the latter are making
clinical decisions, they were not surveyed because we tar-
geted those physicians who were primarily in charge of is-
suing orders for and managing inpatients. One researcher
contacted the resident physicians in each department to
ask them to participate on a voluntary basis, and then re-
trieved the questionnaires with informed consents two
weeks later. No incentives for participation were provided.
The questionnaire was based upon prior research and
revised after review by infectious disease physicians and
professionals in our institution [12, 13]. Consisting of 12
questions about bacteriuria and 4 demographic ques-
tions, the questionnaire was divided into three dimen-
sions; 1) assessment of knowledge using seven brief
clinical vignettes, 2) evaluation of perceptions, 3) under-
standing of actual practice. In the knowledge assessment
part, respondents were provided different virtual clinical
cases which we had developed for the survey and were
asked to select one of three options concerning the diag-
nosis (ABU/ UTI/ uncertain) and management (would
prescribe antibiotics/ would not prescribe antibiotics/
not sure) for each vignette. The knowledge score was
measured by the proportion of correct answers. The per-
ception part consisted of questions focused on the clin-
ical approach to bacteriuria; 1) reasons for ordering
urine cultures, 2) reactions to abnormal urinalysis find-
ings, 3) factors to consider in diagnosing UTI. The prac-
tice part included questions about adhering to the
guidelines in reality and perceived reasons for incorrect
practices. The demographic questions consisted of gen-
der, age, training level, and affiliated department. The
questionnaire is presented in more detail in Additional
file 1.
Statistical analysis
Fisher’s exact test or the chi-square test was used to
compare categorical variables, and the Mann–Whitney
U test for comparison of continuous data. Variables with
a P value < 0.1 in univariate analysis were included in a
multivariate analysis using logistic regression to identify
factors associated with inappropriate treatment of ABU.
All P values were two-tailed, and statistical significance
was accepted at a P value < 0.05. PASW for Windows
(version 18 software package; SPSS Inc., Chicago, IL,
USA) was used for the analysis.
Results
Inappropriate antibiotic use in ABU
A total of 6,269 urine cultures were performed among
adult inpatients during the study period, of which 1,529
grew microorganisms. Among these we identified 1,167
episodes of positive urine cultures that grew ≥105 cfu/
mL, and another 362 episodes with lower counts. As
shown in Fig. 1, 683 episodes of bacteriuria were ex-
cluded. Among the remaining 484 cases of bacteriuria,
219 cases were classified as ABU. These 219 ABU epi-
sodes involved 183 patients, of which 149 (68.0 %) were
appropriately managed whereas 70 (32.0 %) were in-
appropriately treated with antibiotics.
A comparison of the two groups is shown in Table 1.
The median age was higher in the inappropriately-
managed group (P = 0.014) and female gender, pyuria,
hematuria, bacteriuria, positive nitrite on urinalysis,
and gram negative organism on urine culture were all
related to unnecessary antibiotic use in univariate ana-
lysis. In multivariate analysis, patient age, female gen-
der, pyuria, hematuria, and positive nitrite on urinalysis
Fig. 1 Flow chart of case enrollment and classification
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were significantly associated with inappropriate man-
agement of ABU (P < 0.05, by logistic regression).
The patients who were inappropriately treated were
prescribed antibiotics for a median of six days (inter-
quartile range 4 – 8 days). Ciprofloxacin (67.1 %), third-
generation cephalosporins (25.7 %), and ertapenem
(4.3 %) were the most frequently used antibiotics.
Survey of resident physicians
Of 128 residents, 95 (50 from medical departments and
45 from surgical) completed the questionnaire, giving
an overall response rate of 74.2 %. Of the respondents,
66.3 % were male, and the median age was 29 years
(interquartile range, 27–31 years). In terms of stage of
training, 30 (31.6 %) were in their first year, 24 (25.3 %)
in their second, 21 (22.1 %) in their third, and 20
(21.1 %) in their fourth.
The mean frequency (± SD) of correct responses to
the seven clinical vignettes was 37.3 % (±26.7 %), and
there was a significant difference between the special-
ties that were being followed; 44.0 % (±30.0 %) for
those in medical departments, 29.8 % (±20.4 %) for
those in surgical departments (P = 0.008). No signifi-
cant association was found between the knowledge
score and stage of training (P = 0.92). In general, the
respondents showed poor recognition of ABU (33.7 %)
and also had a limited understanding of the indications
for antibiotic use (20.0 %), judging from the responses
to the clinical vignettes involving ABU (Table 2).
Nevertheless, most of the respondents were aware that
antibiotics were not indicated for ABU, as shown by
the > 90 % correct responses concerning treatment in
the vignettes describing ABU for which no therapy was
needed (Table 2).
All of the respondents answered that they would not
initiate antibiotics simply for abnormal urinalysis re-
sults, but would try to make a reasoned decision con-
cerning antibiotic prescription based on symptoms or
signs suggesting UTI, repeated urinalysis or urine cul-
ture results, and other laboratory findings. However,
they tended to order urine cultures unnecessarily in
asymptomatic patients for the following reasons: to
Table 1 Comparison between patients with appropriately-managed and inappropriately-managed ABUa
Univariate analysis Multivariate analysis
Variables Appropriately- managed ABU Inappropriately- managed ABU OR P
value
aOR P
value(n = 149) (n = 70) (95 % CI) (95 % CI)
Age (year) (median, IQR) 69 (57–77) 73 (69–80) 0.014 1.03 (1.00-1.06) 0.040
Body temperature ≥37.8 °C 17 (11.4) 2 (2.9) 0.23 (0.05-1.02) 0.036 0.34 (0.06-2.07) 0.243
Female gender 100 (67.1) 61 (87.1) 3.32 (1.52-7.24) 0.002 3.38 (1.19-9.66) 0.023
Admission to surgical
departmentb
51 (34.2) 25 (35.7) 1.07 (0.59-1.94) 0.829
Urinary catheterization 73 (49.0) 40 (57.1) 1.39 (0.78-2.46) 0.260
Stay in ICU 11 (7.4) 6 (8.6) 1.18 (0.42-3.32) 0.759
Underlying diseases
Diabetes mellitus 54 (36.2) 27 (38.6) 1.11 (0.62-1.98) 0.739
Chronic kidney disease 17 (11.4) 2 (2.9) 0.23 (0.05-1.02) 0.036 0.23 (0.04-1.26) 0.090
Spinal cord injury 6 (4.0) 5 (7.1) 1.83 (0.54-6.23) 0.325
Cancer 23 (15.4) 9 (12.9) 0.81 (0.78-2.46) 0.614
Leukocytosis (WBC >104/mm3) 36 (24.2) 24 (34.8) 1.67 (0.90-3.12) 0.102
Elevated CRP (>0.5 mg/dL) 100 (67.1) 40 (57.1) 1.00 (0.47-2.15) 1.0
Urinalysis
Pyuria 105 (70.5) 65 (92.9) 5.45 (2.05-14.45) <0.001 4.07 (1.30-12.71) 0.016
Hematuria 44 (29.5) 37 (52.9) 2.68 (1.49-4.81) 0.001 4.48 (2.09-9.58) <0.001
Bacteriuria 118 (79.2) 66 (94.3) 4.34 (1.47-12.82) 0.004 2.39 (0.63-9.10) 0.200
Nitrite positivity 51 (34.2) 52 (74.3) 5.55 (2.95-10.46) <0.001 2.21 (1.01-4.85) 0.048
Urine culture
Gram negative bacteria 85 (57.0) 63 (90.0) 6.78 (2.91-15.78) <0.001 2.06 (0.66-6.39) 0.213
Note. Data are no. (%) of patients
a Variables with a P value < 0.1 in the univariate analysis were included in the multivariate logistic regression analysis
b Includes General Surgery, Neurosurgery, Orthopedic Surgery, Thoracic Surgery, Urology, Otorhinolaryngology, Obstetrics and Gynecology, and Ophthalmology
Abbreviation: ABU asymptomatic bacteriuria, CI confidence interval, OR odds ratio, aOR adjusted odds ratio, IQR interquartile range, ICU intensive care unit, WBC
white blood cell, CRP C-reactive protein
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identify occult infection even in cases without compatible
symptoms or signs; reflexively in response to abnormal
urinalysis results; and for preoperative surveillance.
About half of the respondents (46.3 %) confessed to
prescribing antibiotics for ABU despite knowing they
were not indicated. There was no association between
self-reported discordant practice and mean knowledge
scores (P = 0.18) or stage of training (P = 0.41). Self-
perceived reasons for initiating antibiotics despite a
diagnosis of ABU were: concern about ABU leading to
postoperative infectious complications (38.6 %) or
symptomatic UTI (9.1 %); elevated inflammatory markers
(36.4 %) and abnormal urinalysis results (29.5 %). Concern
about postoperative infection was higher among surgical
residents than non-surgical residents (38.6 % vs 0 %,
P < 0.001).
Discussion
We set out to determine why antibiotics are overpre-
scribed for ABU by evaluating both patient and phys-
ician factors associated with inappropriate treatment of
ABU. About one-third of ABUs were overtreated against
guidelines, in agreement with earlier studies [4–6]. Fe-
male gender, old age, and pyuria, hematuria, and positive
nitrite on urinalysis were the patient clinical factors con-
tributing to antibiotic overuse, while lack of knowledge,
misperception of the clinical implications of bacteriuria,
and discordance between knowledge and practice were
the physician-related factors. One strength of our study
is that we have attempted to identify such patient- and
physician-related factors, as most previous studies fo-
cused on clinical factors or physicians’ knowledge and
attitudes alone [4–6, 12, 13]. Furthermore, our data are
valuable because of the high response rate to the survey
(74.2 %) compared to previous studies and the participa-
tion of physicians from a variety of departments, all of
which can be helpful for developing effective antimicro-
bial stewardship programs and interventions [12, 13].
Pyuria was the most important clinical factor related
to inappropriate antibiotic treatment of ABU. However,
pyuria itself does not distinguish UTI from ABU nor
does it indicate antibiotic use, being commonly found
in patients with ABU, ranging from 30 % in young
women to 90 % in the elderly or hemodialysis patients
[3, 10, 18, 19]. This finding agrees with the survey re-
sult that 29.5 % of respondents prescribed antibiotics
for ABU in actual practice for abnormal urinalysis re-
sults, regardless of the presence or absence of urinary
symptoms. We assume that physicians find it difficult
to neglect pyuria despite the absence of urinary symp-
toms, or that they find it difficult to distinguish UTI
from ABU with pyuria. Likewise, physicians seemed to
have serious concerns about the possibility of UTI de-
veloping in the elderly, and about women with ABU,
Table 2 Summary of clinical vignettes with the corresponding proportions of correct responses










1. A 50-year-old man with hypertension was seen for annual physical exam,
with no urinary symptoms. Routine UA showed pyuria; UC grew ≥105/ml of
Escherichia coli.
ABU, no treatment is
needed
31/95 (32.6) 31/31 (100)
2. A 70-year-old woman with recurrent UTI history admitted due to
trauma, without urinary symptoms. UA showed pyuria; UC grew
≥105/ml of Escherichia coli.
ABU, no treatment is
needed
42/95 (44.2) 39/42 (92.9)
3. A 68-year-old man with an indwelling foley catheter had cloudy urine,
without urinary symptoms or signs of infection. UA showed pyuria; UC grew
≥105/ml of Klebsiella pneumoniae.
ABU, no treatment is
needed
19/95 (20.0) 18/19 (94.7)
4. A 82-year-old woman without urinary symptoms was seen preoperatively
before total knee arthroplasty. A preoperative UC grew ≥105/ml of Klebsiella
pneumoniae.
ABU, no treatment is
needed
37/95 (38.9) 34/37 (91.9)
5. A pregnant woman at 12 weeks’ gestation without urinary symptoms




29/95 (30.5) 17/29 (58.6)
6. A 75-year-old man was about to undergo transurethral resection of the
prostate. A preoperative UC grew ≥105/ml of Klebsiella pneumoniae.
ABU, indicated for
antibiotic therapy
34/95 (35.8) 21/34 (61.8)
7. A 68-year-old woman admitted to the ICU with altered mentality due to
drug intoxication developed SIRS. She had an indwelling Foley catheter. UC




89/95 (93.7) 88/89 (98.9)
Note. Clinical vignettes provided on the questionnaire are virtual cases developed for the purpose of surveying resident physicians
Abbreviation: UA urinalysis, UC urine culture, ABU asymptomatic bacteriuria, UTI urinary tract infection, ICU intensive care unit, SIRS systemic inflammatory
response syndrome
Lee et al. BMC Infectious Diseases  (2015) 15:289 Page 5 of 7
even though ABU is prevalent in these groups. These
results are consistent with earlier studies which re-
ported pyuria, old age, and type of organism as factors
promoting antibiotic overuse for ABU [4, 5]. Therefore,
education about the differential diagnosis of pyuria and
the interpretation of urinalysis is required to improve
the understanding and management of bacteriuria.
Our survey demonstrated an overall paucity of know-
ledge regarding bacteriuria and considerable knowledge
vs. gaps in practice among physicians. This agrees with
previous surveys reporting resident physicians’ (48 %) and
healthcare providers’ (56-71 %) poor knowledge regarding
urine testing and guidelines about ABU, although the
mean level of knowledge was lower in our survey (37.3 %)
[13, 20]. For the clinical vignettes describing ABU where
antibiotics were not indicated, about one third of the re-
spondents correctly chose both the diagnosis and manage-
ment. Most of the physicians who were able to diagnose
ABU said antibiotics should not be used for such cases,
whereas those who could not identify ABU opted to initi-
ate antibiotics. However, for the vignettes describing ABU
that required treatment (pregnancy, prior to transurethral
resection of prostate), only half of the respondents who
made a correct diagnosis were aware of the need for anti-
biotics. Therefore, we suppose that the 32.0 % rate of in-
appropriately managed ABU in the retrospective chart
review is mainly due to physicians’ misdiagnosis of ABU
as UTI, and may be influenced by various clinical factors
that confuse physicians about the diagnosis. To improve
the current situation, clinical scenario-based education,
not just dependence on guidelines or textbooks, and
specific trainee-centered education may be helpful consid-
ering the inter-specialty difference in knowledge demon-
strated by the survey.
From the survey, we could see that urine cultures were
often ordered regardless of the probability of UTI for
various reasons mostly associated with misunderstand-
ing of bacteriuria. This effect was also evident in our re-
view of bacteriuria cases, as the indications for urine
culture were often not clarified on the medical records.
Concern about ABU being a risk factor for postoperative
infection or symptomatic UTI lead physicians to check
for the presence of bacteriuria, and thereafter to un-
necessary antimicrobial use to eradicate ABU. Although
concern about postoperative infection originating from
ABU is prevalent among surgeons, especially in pros-
thesis implant surgery, evidence is mounting that neither
routine urine culture in asymptomatic patients nor pre-
operative eradication of ABU is useful [21, 22]. Although
this remains controversial, we generally do not recom-
mend treating ABU before hip arthroplasty in the study
hospital. In addition, a recent study has shown that sup-
pressing reports of urine culture results ordered for non-
catheterized patients was effective in reducing reflexive
antibiotic use for ABU [23]. Therefore, we suggest that re-
ducing unindicated urine cultures may be the first step to
decreasing antibiotic misuse and to improving physicians’
recognition of the difference between UTI and ABU.
We found considerable discrepancies between know-
ledge, perception and clinical practice, which made the
physician factor significant in relation to the inappropri-
ate treatment of ABU. Nearly half of the respondents
acknowledged that their own actual practice was at vari-
ance with their knowledge. Although the majority of the
respondents agreed that patients’ symptoms or signs
were important for the diagnosis of UTI and none opted
to initiate antibiotics reflexively for abnormal urinalysis
results, the lack of documented explanations of the ra-
tionale for antibiotic use for bacteriuria indicates a
prevalent discrepancy between practice and perception.
Such attitudes of physicians were alluded to in a previ-
ous survey of the management of bacteriuria by inten-
sive care unit clinicians [12]. Practice-based audit, and
feedback to help physician detect the errors of their
practices, as well as fundamental educational efforts are
of critical importance in overcoming this gap. Further
studies are needed to explore the drivers of physician
practice that contradicts their knowledge.
Our partly retrospective, partly prospective study has a
few limitations. First, there may have been some mis-
classification of episodes of bacteriuria because of the
retrospective part of the study. However, to minimize
possible biases incurred from a retrospective review,
three ID specialists independently participated in the
classification and evaluation of the appropriateness of
antibiotic use. Second, our study was conducted in an
acute care hospital, so our result may not be generalizable
to other situations such as long-term care facilities where
ABU is much more prevalent. Third, as we surveyed
physicians in the year after the care was provided
(2012), some of the residents were not the same as those
who actually cared for the episodes of bacteriuria in 2011.
However, we believe that the inappropriate antibiotic use
data can still be reasonably linked and correlated with
the survey considering that the majority of the residents
surveyed did practice in 2011.
Conclusions
About one third of ABUs are overtreated and female gen-
der, old age, and abnormal urinalysis results are associated
with such inappropriate treatment. Physician-related fac-
tors including knowledge deficit, cognitive biases, and dis-
crepancies between perception and practice are factors
that could be modified to reduce antibiotic overuse for
ABU. Therefore, interventions addressing both education
to improve knowledge, and audit and feedback to over-
come the barriers to following guidelines, are warranted.
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